$PCRX
Pacira BioSciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$36.38
▼-0.03%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePacira BioSciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is PCRX down today? It is at $36.38 (-0.03%), and our scanner flagged it 72 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PCRX spikes, and full due diligence on PCRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PCRX 72 times in the last 30 days. Create a free account to track $PCRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PCRX from our scanner (live price and day move above). Fresh from the SEC: Pacira BioSciences, Inc.: Viatris Agrees to Acquire Pacira. A material company disclosure like this is often the real catalyst behind a move of this size.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Slonin Jonathan Officer | Sold (automatic/other) | -3K | sold 1.4% | 216K | $71K at $23.23 | Aug 17, 26 |
Riker Lauren Officer | Sold (automatic/other) | -6K 0.02% of company | sold 8.9% | 62K | $144K at $23.50 | Jun 11, 26 |
Froimson Mark Director | Acquired (grant/award) | +6K 0.02% of company | added 32% | 27K | n/a | Jun 10, 26 |
Brege Laura Director | Acquired (grant/award) | +6K 0.02% of company | added 27% | 30K | n/a | Jun 10, 26 |
Bigal Marcelo Director | Acquired (grant/award) | +6K 0.02% of company | added 56% | 18K | n/a | Jun 10, 26 |
Yang Michael J. Director | Acquired (grant/award) | +6K 0.02% of company | added 48% | 20K | n/a | Jun 10, 26 |
Young Alethia Director | Acquired (grant/award) | +6K 0.02% of company | added 56% | 18K | n/a | Jun 10, 26 |
Christie Christopher Director | Acquired (grant/award) | +6K 0.02% of company | added 38% | 23K | n/a | Jun 10, 26 |
Hirawat Samit Director | Acquired (grant/award) | +6K 0.02% of company | n/a | 6K | n/a | Jun 10, 26 |
Williams Kristen Officer | Sold (automatic/other) | -10K 0.03% of company | sold 5.8% | 167K | $228K at $22.27 | Jun 4, 26 |
Williams Kristen Officer | Sold (automatic/other) | -9K 0.02% of company | sold 4.6% | 177K | $190K at $22.32 | Jun 3, 26 |
Slonin Jonathan Officer | Sold (automatic/other) | -5K 0.01% of company | sold 2.1% | 219K | $106K at $22.32 | Jun 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PCRX from our scanner (live price and day move above). Fresh from the SEC: Pacira BioSciences, Inc.: Viatris Agrees to Acquire Pacira. A material company disclosure like this is often the real catalyst behind a move of this size.
PCRX last traded at $36.38, down 0.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pacira BioSciences, Inc. Common Stock (PCRX) is next expected to report earnings on Thursday, November 5, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PCRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PCRX 72 times in the last 30 days.
PCRX (Pacira BioSciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1.45B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PCRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PCRX discussion
Sign in to ask a question or join the discussion.